Stereochemistry of 4-Vinylcyclohexene Biotransformation
Chem. Res. Toxicol., Vol. 16, No. 1, 2003 57
enantioselectivity (12). It was observed that the endo-
cyclic epoxides, (1R,2S,4R)-trans-3b and (1S,2R,4R)-cis-
2b, whose formation was favored in phenobarbital-
induced microsomes, had also a major resistance to the
enzymatic hydrolysis. Therefore, these epoxides are
expected to accumulate in the liver and undergo further
oxidation in a stereochemical manner to specific reactive
diepoxides. In the present work, we have investigated the
stereochemical and mechanistic aspect of the second step
of VCH metabolism. By using liver microsomes from rats
pretreated with phenobarbital (PB), pyrazole (PYR),
dexamethasone (DEX), and purificated rat P4502B1 or
P4502E1, we have examined the stereochemistry of the
oxidation of endocyclic cis- and trans-VCH-1,2-epoxides
to the isomeric diepoxides. Subsequently, we have studied
the stereoselectivity of the mEH-catalyzed hydrolysis of
the racemic diepoxides to epoxydiols.
F igu r e 1. Gas chromatographic separation of a mixture (ca.
2:8) of monepoxides (1S,2R,4R)-cis-2 and (1R,2S,4R)-trans-3
arising from enzymatic resolution of the commercial mixture
of (()-cis-2 and (()-trans-3. Analysis conditions are outlined in
the Materials and Methods.
46.7 (epoxide CH2); 46.8 (epoxide CH); 47.0 (epoxide CH); 71.2
(CHOH); 71.5 (CHOH); 73.8(CHOH); 74.0 (CHOH).
(1R,2S,4R)-tr a n s-4-Vin ylcycloh exen e 1,2-Ep oxid e (3b)
was prepared by enzymatic kinetic resolution of a 1:1 mixture
of monoepoxides cis-2 and trans-3 using a bovine liver microso-
mal preparation. An ethanolic stock solution (0.2 mL) of the
mixture of (()-cis-2 and (()-trans-3 (160 mg) was added to 6
mL of bovine liver microsomal preparation, containing 5 mg of
protein/mL, at pH 7.4 (Tris-HCl), and the mixture was incubated
with shaking at 37 °C. After 6 h, a saturating amount of NaCl
was added to precipitate the microsomal proteins and the
incubation mixture was extracted with hexane (3 × 10 mL) to
remove the unreacted epoxide. The organic phase was dried
Ma ter ia ls a n d Meth od s
Ca u tion ! The following chemicals are hazardous and should
be handled carefully: 4-vinyl cyclohexene, 4-vinylcyclohexene 1,2-
epoxide, 4-vinylcyclohexene 7,8-epoxide, 4-vinylcyclohexene diep-
oxide.
Ma ter ia ls. DEX, PYR, and â-NF were obtained from common
commercial sources. PB is a control drug and was sold by Fluka
(Buchs, Switzerland) only for research purpose. 4-Vinyl cyclo-
hexene (1), 4-vinylcyclohexene 1,2-epoxide (1:1 mixture of cis-2
and trans-3) and 4-vinylcyclohexene diepoxide (mixture of four
cis-9 isomers and four trans-10 isomers) were purchased from
Aldrich Chemical Co (Milwaukee, WI). TCPO was obtained from
EGA-Chemie (Steinheim-Albuch, Germany). (S)-4-Vinylcyclo-
hexene (1a ), (()-4-vinylcyclohexene 7,8-epoxide (4), (()-4-vinyl-
cyclohexene 7,8-epoxide (5), (()-4-vinylcyclohexene 1,2-diol (6),
(()-4-vinylcyclohexene 7,8-diol (7) and (()-4-vinylcyclohexene
7,8-diol (8), (4S,7S)-4-vinylcyclohexene 7,8-diol (8), (4S,7R)-4-
vinylcyclohexene 7,8-diol (7), (4S,7S)-4-vinylcyclohexene 7,8-
epoxide (5), and (4R,7S)-4-vinylcyclohexene 7,8-epoxide (4) were
prepared as previously reported (12).
(MgSO4) evaporated under reduced pressure to give
a
2:8 mixture of the two monepoxides (1S,2R,4R)-cis-2b and
(1R,2S,4R)-trans-3b or pure (1R,2S,4R)-trans-3b. As shown in
Figure 1, GC analysis was conducted on a 50 m chiral CP-
Cyclodex B (CHROMPACK) column (helium flow of 50 kPa, and
with an evaporator and detector set at 200 °C, at 90 °C).
(1S,2R,4S,7S)-, (1S,2R,4S,7R)-, (1R,2S,4S,7S)-, a n d
(1R,2S,4S,7R)-4-Vin ylcycloh exen e Diepoxide (cis-9a, tr a n s-
10a ). To a solution of m-chloroperbenzoic acid (5 mmol) in
chloroform (15 mL) (S)-4-vinylcyclohexene (1a , 2 mmol) was
added and the mixture was allowed to stay for 2 days at room
temperature and 4 h at 4 °C. The solution was filtered, and 650
mg of KF, previously activated by heating at 120 °C in vacuo (1
mmHg) for 2 h, was added. The mixture was stirred at room
temperature for 1 h; then, the insoluble complexes were filtered
off, and the solvent was removed under reduced pressure to give
a mixture of (1S, 2R, 4S, 7S)-, (1S, 2R, 4S,7R)-, (1R,2S,4S,7S)-,
and (1R,2S,4S,7R)-4-vinylcyclohexene diepoxides (cis-9a and
trans-10a ). The crude product was analyzed by GC (Figure 2;
trace b) on a 25 m Chiraldex G-TA (ASTEC) chiral column at
98 °C (helium flow of 50 kPa, with an evaporator and detector
set at 200 °C).
Mixtu r e of (1R,2S,4S,7R)-cis-4-Vin ylcycloh exen e Diep -
oxid e (9a ) a n d (1S,2R,4S,7R)-tr a n s-4-Vin ylcycloh exen e
Diep oxid e (10a ). The mixture of (1R,2S,4S,7R)-cis-9a and
(1S,2R,4S,7R)-trans-10a was synthesized by epoxidation with
m-chloroperbenzoic acid from (4S,7R)-4-vinylcyclohexene 7,8-
epoxide (4a ), prepared as previously reported (12), according to
the above-reported procedure. The crude product was analyzed
by GC under conditions reported above. Figure 2, trace d.
Mixtu r e of (1R,2S,4S,7S)-cis-4-Vin ylcycloh exen e Diep -
oxid e (9a ) a n d (1S,2R,4S,7S)-tr a n s-4-Vin ylcycloh exen e
Diep oxid e (10a ). To a solution of m-chloroperbenzoic acid (2.5
mmol) in chloroform (10 mL) was added (4S,7S)-4-vinylcyclo-
hexene 7,8-epoxide (5a , 1 mmol), prepared as previously re-
ported (12), and the mixture was allowed to stay for 2 days at
room temperature and 4 h at 4 °C. The solution was filtered,
and 300 mg of KF, previously activated by heating at 120 °C in
vacuo (1 mmHg) for 2 h, was added. The mixture was stirred
at room temperature for 1 h; then the insoluble complexes were
filtered off, and the solvent was removed under reduced pressure
4-Vin ylcycloh exen e 1,2-Ep oxid e-7,8-d iols (11). To a solu-
tion of m-chloroperbenzoic acid (9 mmol) in chloroform (8 mL)
a 1:1 mixture of diols 7 and 8 (3 mmol) was added, and the
mixture was allowed to stay for 16 h at room temperature under
stirring and 4 h at 4 °C. The solution was filtered, and 400 mg
of KF, previously activated by heating at 120 °C in vacuo
(1 mmHg) for 2 h, was added. The mixture was stirred at room
temperature for 1 h; then the insoluble complexes were filtered
off, and the solvent was removed under reduced pressure to give
a mixture of eight diastereoisomeric epoxydiols 11. The crude
product was analyzed by NMR.
1H NMR (CDCl3) δ (ppm): 1.4-2.0 (m, 28H); 2.1-2.5 (m, 8H,
epoxide CH-CH); 3.1-3.7 (m, 12H, CHOH and CH2OH). 13C
NMR and DEPT (CDCl3) δ (ppm): 20.5 (CH2); 21.5(CH2); 23.1
(CH2); 23.1(CH2); 23.3 (CH2); 24.3 (CH2); 24.3 (CH2); 24.5 (CH2);
26.0 (CH2); 26.5 (CH2); 27.2 (CH2); 28.0 (CH2); 33.3 (CH); 33.9
(CH); 36.2 (CH); 36.8 (CH); 50.8 (epoxide CH); 51.4 (epoxide CH);
51.6 (epoxide CH); 51.7 (epoxide CH); 51.8 (epoxide CH); 52.7
(epoxide CH); 52.8(epoxide CH); 53.0 (epoxide CH); 67.8-68.2
(4CH2OH); 79.5 (CHOH); 79.6 (CHOH); 80.1 (CHOH);
80.2(CHOH).
4-Vin ylcycloh exen e 1,2-Diol-7,8-ep oxid es (12). The mix-
ture of four diastereoisomeric epoxydiols 12 was synthesized by
epoxidation with m-chloroperbenzoic acid from (()-4-vinyl-
cyclohexene 1,2-diol (6), according to the above-reported proce-
dure. The crude product was analyzed by NMR.
1H NMR (CDCl3) δ (ppm): 1.4-2.0 (m, 14H); 2.5 (m, 2H,
epoxide CH); 2.7 (m, 2H, epoxide CH); 2.9 (m, 2H, epoxide CH);
3.4 (m, 2H, CHOH); 3.6 (m, 2H, CHOH). 13C NMR and DEPT
(CDCl3) δ (ppm): 24.5 (CH2); 25.1 (CH2); 28.4 (CH2); 28.7 (CH2);
30.9 (CH2); 33.2 (CH2); 36.5 (CH); 36.7 (CH); 46.5 (epoxide CH2);
to give
a ca. 1:1 mixture of (1R,2S,4S,7S)-cis-9a and